| Oct 5 |
Bristol-Myers Squibb Company (BMY): A Buzzing AI Health Stock to Add to Your Portfolio
|
| Oct 5 |
These 4 Measures Indicate That Bristol-Myers Squibb (NYSE:BMY) Is Using Debt Reasonably Well
|
| Oct 4 |
Bristol-Myers trades in the green for seventh straight session
|
| Oct 4 |
Q3 pharma and biotech layoffs in charts: More than 1000 each in July and August
|
| Oct 4 |
UMB to refile $6.4B lawsuit against Bristol-Myers by end of next week - report
|
| Oct 4 |
Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
|
| Oct 4 |
Opdivo gets ‘perioperative’ approval; pharmas cut jobs in New Jersey, Ireland
|
| Oct 4 |
BMS receives FDA approval for Opdivo to treat NSCLC
|
| Oct 3 |
U.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo for Resectable Non-Small Cell Lung Cancer (NSCLC)
|
| Oct 3 |
Bristol-Myers Squibb's Profits, Stock Price Kick Into High Gear
|
